Annual total expenses:
$29.34B+$854.95M(+3.00%)Summary
- As of today (September 17, 2025), TAK annual total expenses is $29.34 billion, with the most recent change of +$854.95 million (+3.00%) on March 1, 2025.
- During the last 3 years, TAK annual total expenses has fallen by -$368.37 million (-1.24%).
- TAK annual total expenses is now -1.74% below its all-time high of $29.86 billion, reached on March 31, 2020.
Performance
TAK Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$6.80B-$789.36M(-10.40%)Summary
- As of today (September 17, 2025), TAK quarterly total expenses is $6.80 billion, with the most recent change of -$789.36 million (-10.40%) on June 1, 2025.
- Over the past year, TAK quarterly total expenses has dropped by -$341.50 million (-4.78%).
- TAK quarterly total expenses is now -17.09% below its all-time high of $8.20 billion, reached on December 31, 2019.
Performance
TAK Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TAK Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.0% | -4.8% |
| 3 y3 years | -1.2% | +1.8% |
| 5 y5 years | -1.7% | +1.6% |
TAK Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.2% | +7.2% | -10.4% | +1.8% |
| 5 y | 5-year | -1.7% | +10.3% | -10.6% | +25.9% |
| alltime | all time | -1.7% | +538.9% | -17.1% | +282.5% |
TAK Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $6.80B(-10.4%) |
| Mar 2025 | $29.34B(+3.0%) | $7.59B(+3.2%) |
| Dec 2024 | - | $7.35B(+1.2%) |
| Sep 2024 | - | $7.26B(+1.7%) |
| Jun 2024 | - | $7.14B(+0.6%) |
| Mar 2024 | $28.49B(+4.1%) | $7.10B(+4.4%) |
| Dec 2023 | - | $6.80B(-9.9%) |
| Sep 2023 | - | $7.55B(+7.1%) |
| Jun 2023 | - | $7.05B(+0.9%) |
| Mar 2023 | $27.38B(-7.9%) | $6.99B(+1.1%) |
| Dec 2022 | - | $6.91B(+1.7%) |
| Sep 2022 | - | $6.80B(+1.8%) |
| Jun 2022 | - | $6.68B(-12.2%) |
| Mar 2022 | $29.71B(+11.7%) | $7.61B(+2.5%) |
| Dec 2021 | - | $7.42B(+2.2%) |
| Sep 2021 | - | $7.26B(-2.2%) |
| Jun 2021 | - | $7.42B(+37.4%) |
| Mar 2021 | $26.61B(-10.9%) | $5.40B(-24.2%) |
| Dec 2020 | - | $7.12B(-3.7%) |
| Sep 2020 | - | $7.39B(+10.5%) |
| Jun 2020 | - | $6.69B(-5.3%) |
| Mar 2020 | $29.86B(+68.8%) | $7.06B(-13.9%) |
| Dec 2019 | - | $8.20B(+18.4%) |
| Sep 2019 | - | $6.93B(-9.6%) |
| Jun 2019 | - | $7.66B(+13.0%) |
| Mar 2019 | $17.69B(+23.8%) | $6.78B(+65.6%) |
| Dec 2018 | - | $4.09B(+19.3%) |
| Sep 2018 | - | $3.43B(+0.8%) |
| Jun 2018 | - | $3.40B(-19.0%) |
| Mar 2018 | $14.29B(-4.3%) | $4.20B(+12.9%) |
| Dec 2017 | - | $3.72B(+1.9%) |
| Sep 2017 | - | $3.65B(+33.7%) |
| Jun 2017 | - | $2.73B(-33.6%) |
| Mar 2017 | $14.93B(+3.8%) | $4.11B(+6.3%) |
| Dec 2016 | - | $3.87B(+1.0%) |
| Sep 2016 | - | $3.83B(+23.6%) |
| Jun 2016 | - | $3.10B(-20.3%) |
| Mar 2016 | $14.38B(-17.9%) | $3.89B(+9.8%) |
| Dec 2015 | - | $3.54B(+1.1%) |
| Sep 2015 | - | $3.50B(+0.9%) |
| Jun 2015 | - | $3.47B(-37.6%) |
| Mar 2015 | $17.51B(+10.7%) | $5.57B(+35.5%) |
| Dec 2014 | - | $4.11B(+3.7%) |
| Sep 2014 | - | $3.96B(+7.1%) |
| Jun 2014 | - | $3.70B(-10.7%) |
| Mar 2014 | $15.82B(-6.9%) | $4.14B(+0.9%) |
| Dec 2013 | - | $4.11B(+6.2%) |
| Sep 2013 | - | $3.87B(+0.2%) |
| Jun 2013 | - | $3.86B(-5.3%) |
| Mar 2013 | $16.99B | $4.08B(-13.6%) |
| Dec 2012 | - | $4.72B(+4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $4.53B(+16.8%) |
| Jun 2012 | - | $3.88B(-26.3%) |
| Mar 2012 | $17.54B(+28.2%) | $5.26B(+1.7%) |
| Dec 2011 | - | $5.18B(+40.9%) |
| Sep 2011 | - | $3.67B(+6.3%) |
| Jun 2011 | - | $3.45B(-7.1%) |
| Mar 2011 | $13.68B(+8.7%) | $3.72B(+2.8%) |
| Dec 2010 | - | $3.62B(+9.7%) |
| Sep 2010 | - | $3.30B(+3.4%) |
| Jun 2010 | - | $3.19B(-3.4%) |
| Mar 2010 | $12.58B(-3.0%) | $3.30B(-2.1%) |
| Dec 2009 | - | $3.37B(+5.4%) |
| Sep 2009 | - | $3.20B(+17.0%) |
| Jun 2009 | - | $2.74B(-4.9%) |
| Mar 2009 | $12.96B(+45.4%) | $2.88B(-7.4%) |
| Dec 2008 | - | $3.11B(-1.9%) |
| Sep 2008 | - | $3.17B(-15.3%) |
| Jun 2008 | - | $3.74B(+43.5%) |
| Mar 2008 | $8.92B(+7.6%) | - |
| Mar 2008 | - | $2.61B(+16.1%) |
| Dec 2007 | - | $2.25B(+3.7%) |
| Sep 2007 | - | $2.17B(+12.0%) |
| Jun 2007 | - | $1.93B(-0.3%) |
| Mar 2007 | $8.29B(+4.4%) | - |
| Mar 2007 | - | $1.94B(-10.1%) |
| Dec 2006 | - | $2.16B(-8.2%) |
| Sep 2006 | - | $2.35B(+27.4%) |
| Jun 2006 | - | $1.85B(-11.8%) |
| Mar 2006 | $7.94B(+1.0%) | - |
| Mar 2006 | - | $2.10B(+5.0%) |
| Dec 2005 | - | $1.99B(+1.6%) |
| Sep 2005 | - | $1.96B(+6.8%) |
| Jun 2005 | - | $1.84B(-12.7%) |
| Mar 2005 | $7.87B(+10.9%) | - |
| Mar 2005 | - | $2.11B(-1.4%) |
| Dec 2004 | - | $2.14B(+20.2%) |
| Sep 2004 | - | $1.78B(-5.8%) |
| Jun 2004 | - | $1.89B |
| Mar 2004 | $7.09B(+11.6%) | - |
| Mar 2003 | $6.35B(+3.2%) | - |
| Mar 2002 | $6.16B(-16.6%) | - |
| Mar 2001 | $7.38B(+2.3%) | - |
| Mar 2000 | $7.22B(+21.8%) | - |
| Mar 1999 | $5.93B(-4.3%) | - |
| Mar 1998 | $6.19B(-8.9%) | - |
| Mar 1997 | $6.80B(-11.6%) | - |
| Mar 1996 | $7.69B(+5.0%) | - |
| Mar 1995 | $7.32B(+15.2%) | - |
| Mar 1994 | $6.36B(+17.3%) | - |
| Mar 1993 | $5.42B(+6.4%) | - |
| Mar 1992 | $5.10B(+10.9%) | - |
| Mar 1991 | $4.59B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total expenses?
- What is the all time high annual total expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual total expenses year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total expenses?
- What is the all time high quarterly total expenses for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly total expenses year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total expenses?
The current annual total expenses of TAK is $29.34B
What is the all time high annual total expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total expenses is $29.86B
What is Takeda Pharmaceutical Company Limited annual total expenses year-on-year change?
Over the past year, TAK annual total expenses has changed by +$854.95M (+3.00%)
What is Takeda Pharmaceutical Company Limited quarterly total expenses?
The current quarterly total expenses of TAK is $6.80B
What is the all time high quarterly total expenses for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total expenses is $8.20B
What is Takeda Pharmaceutical Company Limited quarterly total expenses year-on-year change?
Over the past year, TAK quarterly total expenses has changed by -$341.50M (-4.78%)